May 14 |
Curis Announces Additional Data from TakeAim Leukemia Study
|
May 10 |
Curis to Present Updated Data from the TakeAim Leukemia Study
|
May 8 |
Curis, Inc. (NASDAQ:CRIS) Q1 2024 Earnings Call Transcript
|
May 8 |
Curis, Inc. (CRIS) Q1 2024 Earnings Call Transcript
|
May 7 |
Curis GAAP EPS of -$2.05, revenue of $2.1M
|
May 7 |
Curis Provides First Quarter 2024 Business Update
|
May 6 |
Curis Q1 2024 Earnings Preview
|
Apr 30 |
Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024
|
Apr 12 |
Top 3 Health Care Stocks That May Collapse In Q2
|
Apr 5 |
Strength Seen in Curis (CRIS): Can Its 19.5% Jump Turn into More Strength?
|